The Orthopedic biomaterials market is projected to grow at a rate of 8.70% in terms of value, from 2020 to reach USD 28.38 Billion by 2028. The growth of the market may be attributed to the rise in the prevalence of target conditions. Rising occurrences of chronic skeletal conditions are anticipated to drive the market growth in the forecast period. Skeletal fragility related to childhood chronic disease is a general disorder of poor bone growth and decrease in bone turnover, resulting in abnorm...